| 000 | 02410 a2200709 4500 | ||
|---|---|---|---|
| 005 | 20250517163003.0 | ||
| 264 | 0 | _c20180611 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1421-9786 | ||
| 024 | 7 |
_a10.1159/000477501 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShah, Zubair | |
| 245 | 0 | 0 |
_aOptimal Medical Management Reduces Risk of Disease Progression and Ischemic Events in Asymptomatic Carotid Stenosis Patients: A Long-Term Follow-Up Study. _h[electronic resource] |
| 260 |
_bCerebrovascular diseases (Basel, Switzerland) _c2017 |
||
| 300 |
_a150-159 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAsymptomatic Diseases |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBrain Ischemia _xepidemiology |
| 650 | 0 | 4 |
_aCarotid Stenosis _xdiagnostic imaging |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aDyslipidemias _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHypertension _xdiagnosis |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xepidemiology |
| 650 | 0 | 4 |
_aKansas _xepidemiology |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPropensity Score |
| 650 | 0 | 4 | _aProtective Factors |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aRisk Reduction Behavior |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSmoking _xadverse effects |
| 650 | 0 | 4 | _aSmoking Cessation |
| 650 | 0 | 4 |
_aStroke _xepidemiology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUltrasonography, Doppler, Duplex |
| 700 | 1 | _aMasoomi, Reza | |
| 700 | 1 | _aThapa, Rashmi | |
| 700 | 1 | _aWani, Mashhood | |
| 700 | 1 | _aChen, John | |
| 700 | 1 | _aDawn, Buddhadeb | |
| 700 | 1 | _aRymer, Marilyn | |
| 700 | 1 | _aGupta, Kamal | |
| 773 | 0 |
_tCerebrovascular diseases (Basel, Switzerland) _gvol. 44 _gno. 3-4 _gp. 150-159 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000477501 _zAvailable from publisher's website |
| 999 |
_c27349755 _d27349755 |
||